The Prognostic Role and Utility of Highly Sensitive Minimal Residual Disease Assay in Multiple Myeloma: Is There Really a Difference?

被引：0
|
作者：
Fonseca, Rodrigo [1 ]
Wiedmeier, Julia E. [1 ]
Arribas, Mariano [1 ]
Fonseca, Rafael [1 ]
机构：
[1] Mayo Clin, Phoenix, AZ USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2022年 / 22卷
关键词：
MM; multiple myeloma; minimal; residual disease; next-generation sequencing;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MM-361
引用
收藏
页码：S420 / S420
页数：1
相关论文
共 50 条
  • [1] Controversies in the Assessment of Minimal Residual Disease in Multiple Myeloma: Clinical Significance of Minimal Residual Disease Negativity Using Highly Sensitive Techniques
    Noa Biran
    Scott Ely
    Ajai Chari
    Current Hematologic Malignancy Reports, 2014, 9 : 368 - 378
  • [2] Controversies in the Assessment of Minimal Residual Disease in Multiple Myeloma: Clinical Significance of Minimal Residual Disease Negativity Using Highly Sensitive Techniques
    Biran, Noa
    Ely, Scott
    Chari, Ajai
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2014, 9 (04) : 368 - 378
  • [3] Role of minimal residual disease assessment in multiple myeloma
    Szalat, Raphael E.
    Anderson, Kenneth C.
    Munshi, Nikhil C.
    HAEMATOLOGICA, 2024, 109 (07) : 2049 - 2059
  • [4] Role of minimal residual disease assessment in multiple myeloma
    Szalat, Raphael E.
    Anderson, Kenneth C.
    Munshi, Nikhil C.
    REVISTA CHILENA DE LITERATURA, 2024, (109): : 2049 - 2059
  • [5] Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma
    Flores-Montero, J.
    Sanoja-Flores, L.
    Paiva, B.
    Puig, N.
    Garcia-Sanchez, O.
    Boettcher, S.
    van der Velden, V. H. J.
    Perez-Moran, J-J
    Vidriales, M-B
    Garcia-Sanz, R.
    Jimenez, C.
    Gonzalez, M.
    Martinez-Lopez, J.
    Corral-Mateos, A.
    Grigore, G-E
    Fluxa, R.
    Pontes, R.
    Caetano, J.
    Sedek, L.
    del Canizo, M-C
    Blade, J.
    Lahuerta, J-J
    Aguilar, C.
    Barez, A.
    Garcia-Mateo, A.
    Labrador, J.
    Leoz, P.
    Aguilera-Sanz, C.
    San-Miguel, J.
    Mateos, M-V
    Durie, B.
    van Dongen, J. J. M.
    Orfao, A.
    LEUKEMIA, 2017, 31 (10) : 2094 - 2103
  • [6] Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma
    J Flores-Montero
    L Sanoja-Flores
    B Paiva
    N Puig
    O García-Sánchez
    S Böttcher
    V H J van der Velden
    J-J Pérez-Morán
    M-B Vidriales
    R García-Sanz
    C Jimenez
    M González
    J Martínez-López
    A Corral-Mateos
    G-E Grigore
    R Fluxá
    R Pontes
    J Caetano
    L Sedek
    M-C del Cañizo
    J Bladé
    J-J Lahuerta
    C Aguilar
    A Bárez
    A García-Mateo
    J Labrador
    P Leoz
    C Aguilera-Sanz
    J San-Miguel
    M-V Mateos
    B Durie
    J J M van Dongen
    A Orfao
    Leukemia, 2017, 31 : 2094 - 2103
  • [7] Prognostic value of minimal residual disease response assessment in multiple myeloma
    Takamatsu, Hiroyuki
    ANNALS OF ONCOLOGY, 2015, 26 : 25 - 25
  • [8] The role of minimal residual disease evaluation for patients with multiple myeloma
    Eun, Yoon Sang
    Kim, Hyun-Young
    Cho, Duck
    Kim, Seok Jin
    Kim, Kihyun
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S80 - S80
  • [9] Minimal Residual Disease in Multiple Myeloma
    Munshi, Nikhil C.
    Anderson, Kenneth C.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (20) : 2523 - 2526
  • [10] Minimal residual disease for multiple myeloma
    Avet-Loiseau, Herve
    Corre, Jill
    HEMATOLOGIE, 2019, 25 : 36 - 39
12345